Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 438Triple Negative Breast Neoplasms 50Neoplasm Metastasis 24Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 22Colorectal Neoplasms 18Carcinoma, Intraductal, Noninfiltrating 18Neoplasms 16Pancreatic Neoplasms 14Prostatic Neoplasms 13Brain Neoplasms 13Stomach Neoplasms 12Colonic Neoplasms 11Breast Neoplasms, Male 10Urinary Bladder Neoplasms 8Small Cell Lung Carcinoma 8Melanoma 8Fatigue 8Breast Carcinoma In Situ 8Sarcoma 7Squamous Cell Carcinoma of Head and Neck 6Lymphedema 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Carcinoma, Ovarian Epithelial 6Breast Cancer Female 6Testicular Neoplasms 5Pain 5Esophageal Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Fibroadenoma × Breast × Clear all
NCT03868475 2026-03-09

VAPEX

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Withdrawn
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡